AlaMab Therapeutics (Shanghai) Inc. clinical trials

A subsidiary of CSPC Pharmaceutical Group Limited

The registry lists 3 studies whose lead sponsor is AlaMab Therapeutics (Shanghai) Inc.. 1 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 18, 2025.

Status

Status unknown: 1
Completed: 1
Not yet recruiting: 1

Phase

Phase 2: 2
Phase 1: 2

Where

China: 1

Registry sponsor names on this page

AlaMab Therapeutics (Shanghai) Inc.3 studies

Something wrong with this grouping? Tell us on the CSPC Pharmaceutical Group Limited page.

Studies

Recruiting first, then most recently updated. Showing 3 of 3. All CSPC Pharmaceutical Group Limited studies →

A Study to Evaluate the Efficacy of ALMB-0168 in Solid Tumor Patients With Bone Metastatic Whose Prior Standard Treatment Have FailedNot yet recruitingNCT06416358Phase 2
Sponsor listed in the registry: AlaMab Therapeutics (Shanghai) Inc.
Study to Evaluate the Safety and Pharmacokinetics of ALMB-0166 in Patients With Acute Spinal Cord InjuryCompletedNCT05524103Phase 1
Sponsor listed in the registry: AlaMab Therapeutics (Shanghai) Inc.
A Study to Evaluate the Safety and Efficacy of ALMB-0168 in Patients With OsteosarcomaStatus unknownNCT04886765Phase 1/2
Sponsor listed in the registry: AlaMab Therapeutics (Shanghai) Inc.